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ABSTRACT 
Oxidative stress is thought to contribute to the death of dopamine neurons and the 
consequential progression of Parkinson’s disease.  Redox cycling of quinones, including 
compounds formed by dopamine oxidation, can lead to oxidative stress and damaging of 
the mitochondria.  Which enzymes catalyze the redox cycling of quinones is unknown, 
however.  Inhibitors of the mitochondrial respiratory chain (cyanide, rotenone) do not 
inhibit redox cycling.  Mitochondrial NAD(P)H:quinone oxidoreductases are likely 
candidates, but dicumarol, a common inhibitor of such enzymes is not effective.  We 
observed that Cibacron Blue does indeed inhibit NADH-dependent redox cycling to an 
extent. Our data shows that the rate of oxygen consumption decreased with the addition 
of Cibacron Blue. Moreover, the changes in the mitochondrial membrane potential, 
indicated by fluorescence of the rhodamine dye bound to the membrane, are less 
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significant when the inhibitor was added. Cibacron Blue inhibits a 
quinone:oxidoreductase enzyme and has important implications for the causes of 
Parkinson’s disease. Moreover, another inhibitor, mersalyl acid, has also been identified 
as a potentially more effective blocker to redox cycling, based on the drastic decrease in 
oxygen consumption upon its addition.  
 
INTRODUCTION 
Redox reactions are necessary for all life including humans, as they provide the energy 
for metabolism. However, free radicals and other chemicals produced from redox 
(reduction-oxidation) reactions can damage cells. Enzymes in mitochondria, the energy 
centers of cells, can facilitate these reactions and lead to conditions such as Parkinson’s 
disease. Damage to cells diminishes ATP production and the use of ATP-sensitive 
channels within dopaminergic neurons.  Damage may also trigger apoptosis 
(programmed cell death) and disrupt cell functions more generally. 
 A mitochondrial NAD(P)H:quinone oxidoreductase is the suspected cause of 
redox cycling of quinones, leading to oxidative stress. Quinones are aromatic compounds, 
which can cycle between reduced and oxidized forms.  They are reduced enzymatically 
and oxidized by reacting with molecular oxygen.  This latter reaction produces reactive 
oxygen species including superoxide and hydrogen peroxide and thereby creates 
oxidative stress.  Recently, it has been discovered that Cibacron Blue, an inhibitor, can be 
successful in preventing damaging redox reactions.  
 Our study focuses on redox cycling by catecholamine oxidation products, which 
may relate to the molecular causes of Parkinson's disease. The central question of this 
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research project is to determine which NADH-dependent enzymes are involved in redox 
cycling of quinones and therefore may cause oxidative stress and ultimately kill cells.  
This phenomenon may contribute to a number of common and serious disorders 
including Parkinson’s, Alzheimers and cardiovascular disease.  I used inhibitors, 
including Cibacron blue, dicumarol and chrysin to discriminate among these enzymes.  If 
an inhibitor (e.g., Cibacron Blue) is determined be successful in stopping redox cycling 
by a particular enzyme and it also protects against damage to the cell, this enzyme would 
be implicated in causing oxidative stress.  
 The project is separated into two parts.  The first part measures redox cycling of 
3-methyl-5-anilino-1,2-benzoquinone (MAQ,a test quinone) by NADH-dependent 
enzymes using the oxygen electrode. One enzyme, a mitochondrial NAD(P)H:quinone 
oxidoreductase, is the suspected cause of redox cycling (S. Endo 1326). The hypothesis is 
that this enzyme is inhibited by Cibacron Blue, but not by dicumarol or chrysin, 
inhibitors of other NADH-dependent enzymes previously thought to cause the redox 
cycling.  
 To measure redox cycling further, diaphorase, a cytoplasmic enzyme used to 
catalyze the reduction of dyes, or hydrogen acceptors, will be tested for redox cycling of 
MAQ (R. Li 8846). The hypothesis is that this enzyme is inhibited by dicumarol and 
chrysin, unlike the mitochondrial NADH-dependent enzyme. The question at hand for 
this part of the experiment is to determine if Cibacron Blue is also successful in inhibiting 
cytoplasmic diaphorase as it was successful in inhibiting the mitochondrial NADH-
dependent enzyme.  
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 The second part of the research project measures the destruction of the 
mitochondrial inner membrane potential. There are two major questions in this part of the 
experiment. Do NADH and MAQ together destroy the membrane potential? And also, 
does Cibacron Blue protect the membrane potential from being destroyed? The 
hypothesis here is that when NADH and MAQ are added to mitochondria, redox cycling 
will occur and damage the mitochondrial membrane.  Then, the mitochondrial inner 
membrane will not be able to support a proton gradient and no membrane potential will 
be observed when succinate, an electron donator to the electron transport chain, is added.  
The idea is that Cibacron Blue may be able to prevent this just as it was able to inhibit the 
affects of the enzymes in the first part of the research project.  Dicumarol and chrysin, 
inhibitors of diaphorase, but not of the mitochondrial enzyme, should not have this effect.  
 
MATERIALS AND METHODS 
 
Method for using oxygen electrode: Oxygen concentrations in solutions were measured 
using an oxygen electrode as described by Li et al. (2007). (G. Li 6978). First, the buffer 
(four milliliters) was placed in the chamber of a Clark-type oxygen electrode. Next, the 
enzyme preparation and MAQ were added and the O2 concentration is recorded. After a 
constant baseline is obtained, the NADH was put in the solution and the rate of O2 
consumption is recorded. (The enzyme preparations were obtained from veal brain either 
as mitochondrial (NADH:quinone oxidoreductase) or cytoplasmic (diaphorase) extracts. 
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Method for membrane potential using fluorescence spectrometer: 
Tetramethylrhodaminemethylester (TMRM) fluorescence was used as an indicator of 
membrane potential. TMRM is reddish-colored dye. Its binding to the membrane changes 
with membrane potential, which causes its fluorescence to change. When protons are 
pumped out of the mitochondria (more negative potential) there is less fluorescence. 
Fluorescence was measured using the fluorescence spectrometer. Potassium phosphate 
buffer, mitochondria, and the dye solution were all added together in solution in the 
fluorescence spectrometer. Succinate, capable of donating electrons to the electron 
transport chain used for cellular respiration, was then added to the solution. This causes a 
drop in fluorescence. Membrane potential/fluorescence increases again when oxygen is 
used up and respiration stops. When MAQ is added, there is much less of a membrane 
potential response. Cibacron Blue could help counter the negative effect of MAQ, and 
preliminary tests performed in Dr. Njus’ lab have shown promising results. This method 
served to establish the correlation between the enzyme and the destructive effect on 
membrane potential. 
 
RESULTS 
Two approaches were used to observe the effects of redox cycling inhibitors. First, the 
fluorometer was used to measure the mitochondrial membrane potential changes upon the 
addition of the inhibitor. Changes in membrane potential result when damaging redox 
cycling occurs. Reactive oxygen species formed from the reactions include hydrogen 
peroxide and superoxide. These, produced by enzymes using quinones as substrates, 
                                                                                                 
damage the membrane and prevent the respiration
potential.  
 
 
 
 
 
 
 
 
Effects of NADH and MAQ on mitochondrial membrane potential.
recorded from a suspension of heart mitochondria with the potential
TMRM and NADH and MAQ as indicated.  Succinate was added at t=0 to initiate 
respiration.   The fluorescence drops as proton
                                                  
-dependent change in membrane 
   Fluorescence was 
-sensitive dye 
-pumping changes the membrane potential 
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across the mitochondrial inner membrane.  This fluorescence returns to the original value 
at later times when respiration depletes the oxygen in the solution.  It is apparent that 
redox cycling of MAQ in the presence of NADH diminishes the respiration
change in membrane potential.
 
 
 
Cibacron Blue protects against the redox
Fluorescence was recorded from a suspension of heart mitochondria with the potential
sensitive dye TMRM and NADH and MAQ as indicated.  Succinate was added at t=0 to 
initiate respiration.  The respiration
diminished by NADH and MAQ when Cibacron Blue was present.
 
                                                  
 
-cycling-dependent loss of membrane potential.
-dependent change in membrane potential was not 
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A newly discovered inhibitor, mersalyl acid, has proven to be successful in inhibiting 
radical-forming enzymes. The success is based on trials performed in which the rate of 
oxygen consumption decreased drastically upon the addition of mersalyl acid. Mersalyl is 
an organomercury compound. Its structure is important as it may give insight into how it 
reacts with enzymes that cause oxidative stress. Mersalyl seems to be even more 
productive than the previously successful inhibitor, Cibacron Blue.  
 
 
Comparison between the effects of Cibacron Blue and mersalyl acid in terms of the rate 
of oxygen consumption (measured by the slope of the line). A smaller slope represents a 
slower rate of oxygen consumption and hence, less formation of free radicals: this would 
indicate an inhibitor’s efficacy. While Cibacron Blue is a successful inhibitor as indicated 
by the previous graphs indicating Cibacron Blue’s effect on mitochondrial membrane 
potential, according to the oxygen electrode models, mersalyl is more effective. While 
the slope in the presence of mersalyl acid (indicating the rate of oxygen consumption) 
remains near zero and constant, the slope with Cibacron Blue drops sharply. In essence, 
oxygen is being consumed at a faster rate.  
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Comparison of the rate of oxygen consumption with and without mersalyl acid. After the 
ten minute mark, oxygen consumption increases rapidly without mersalyl acid (indicated 
by a drop in the slope of the line). Meanwhile, with mersalyl acid, the slope stays 
relatively constant and is close to zero. This indicates that very little oxygen, which can 
presumably be used to form free radicals, is being consumed upon the addition of 
mersalyl acid.  
 
CONCLUSIONS 
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Three important conclusions have resulted from this research. First, redox cycling of 
MAQ in the presence of NADH damages the mitochondrial membrane potential. Second, 
Cibacron Blue inhibits a specific quinone oxidoreductase enzyme that catalyzes redox 
cycling that leads to oxidative stress. Finally, mersalyl acid is an effective inhibitor in 
preventing the redox cycling of quinones. Which specific enzyme is inhibited by mersalyl 
acid, however, is unknown. The discovery of inhibitors of redox cycling inducing 
enzymes in dopaminergic neurons may prevent their destruction, and possibly solve the 
mystery of Parkinson’s disease.  
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